MedTrace Logo

Effects of Multiple Doses of CS-8080 in Healthy Volunteers

NCT00796575 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-12-21

No results posted yet for this study

Summary

The main purposes of this study are to assess the safety and measure the pharmacokinetics and pharmacodynamics of CS-8080 in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

CS-8080

CS-8080 1mg tablets, 3 tablets administered 1 times per day

DRUG

placebo tablets

placebo tablets matching active

DRUG

CS-8080

CS-8080 5 mg tablets, 2 tablets administered 1 times per day

DRUG

CS-8080

CS-8080 5 mg tablets, 4 tablets administered 1 times per day

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796575 on ClinicalTrials.gov